End-use Segment Analysis: Medical Device Companies (Largest Segment) vs Pharmaceutical Companies (Fastest-Growing Segment)

Medical device companies represented the largest end-use segment in the offsite sterilization services market, accounting for a 48.51% share in 2026. Their reliance on validated sterilization processes supports the safety and regulatory compliance of a broad range of devices, particularly products requiring controlled microbial reduction without compromising material integrity. Outsourcing sterilization enables manufacturers to access specialized facilities, maintain consistent quality standards, and streamline production while reducing the need for dedicated sterilization infrastructure. Growing complexity in medical device manufacturing and continued emphasis on product safety further reinforce demand from this end-use group.

Pharmaceutical companies are emerging as the fastest-growing end-use segment, supported by increasing requirements for controlled sterilization across pharmaceutical products, packaging components, and manufacturing-related materials. Greater attention to contamination prevention and stringent quality assurance encourages pharmaceutical manufacturers to use specialized external service providers with established sterilization capabilities. The ability to obtain reliable processing while maintaining manufacturing flexibility also supports greater adoption of offsite sterilization services within pharmaceutical production environments.

Service Segment Analysis: Ethylene Oxide Sterilization (Largest Segment) vs Gamma Sterilization (Fastest-Growing Segment)

In the offsite sterilization services market, ethylene oxide sterilization held the largest position, representing a 42.93% share in 2026. Its broad applicability to heat-sensitive and moisture-sensitive medical products makes it particularly valuable for devices containing polymers, electronics, and other materials that may be affected by conventional sterilization methods. The technique supports treatment of complex product geometries while maintaining product functionality, making outsourced ethylene oxide processing an important option for manufacturers seeking dependable sterilization without altering device performance.

Gamma sterilization is gaining adoption at a faster pace as manufacturers seek efficient sterilization approaches capable of processing products in their final packaging. Its ability to provide effective microbial control while supporting continuous processing and compatibility with a range of packaged products strengthens its appeal across healthcare manufacturing applications. Increasing demand for streamlined sterilization workflows and reliable treatment of disposable medical products is supporting the expansion of gamma-based service offerings.